These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28671755)

  • 1. Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.
    Lagarde N; Delahaye S; Jérémie A; Ben Nasr N; Guillemain H; Empereur-Mot C; Laville V; Labib T; Réau M; Langenfeld F; Zagury JF; Montes M
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28671755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.
    Lagarde N; Delahaye S; Zagury JF; Montes M
    J Cheminform; 2016; 8(1):43. PubMed ID: 27602059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
    Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
    J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
    Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
    Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
    Lempiäinen H; Molnár F; Macias Gonzalez M; Peräkylä M; Carlberg C
    Mol Endocrinol; 2005 Sep; 19(9):2258-72. PubMed ID: 15905360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross docking pipeline for improving pose prediction and virtual screening performance.
    Kumar A; Zhang KYJ
    J Comput Aided Mol Des; 2018 Jan; 32(1):163-173. PubMed ID: 28836076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.
    Réau M; Lagarde N; Zagury JF; Montes M
    J Med Chem; 2019 Mar; 62(6):2894-2904. PubMed ID: 30354114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.
    Lagarde N; Zagury JF; Montes M
    J Chem Inf Model; 2014 Oct; 54(10):2915-44. PubMed ID: 25250508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsupervised guided docking of covalently bound ligands.
    Fradera X; Kaur J; Mestres J
    J Comput Aided Mol Des; 2004 Oct; 18(10):635-50. PubMed ID: 15849994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.
    Park SJ; Kufareva I; Abagyan R
    J Comput Aided Mol Des; 2010 May; 24(5):459-71. PubMed ID: 20455005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric Binding Sites On Nuclear Receptors: Focus On Drug Efficacy and Selectivity.
    Fischer A; Smieško M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
    Katari SK; Natarajan P; Swargam S; Kanipakam H; Pasala C; Umamaheswari A
    J Recept Signal Transduct Res; 2016 Dec; 36(6):558-571. PubMed ID: 26906522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.
    Matsuzaka Y; Uesawa Y
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steps towards flexible docking: modeling of three-dimensional structures of the nuclear receptors bound with peptide ligands mimicking co-activators' sequences.
    Kurcinski M; Kolinski A
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):357-60. PubMed ID: 17241780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational discovery of novel nuclear hormone receptor antagonists.
    Schapira M; Raaka BM; Samuels HH; Abagyan R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1008-13. PubMed ID: 10655475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid hormone binding receptors: application of homology modeling, induced fit docking, and molecular dynamics to study structure-function relationships.
    Cornell W; Nam K
    Curr Top Med Chem; 2009; 9(9):844-53. PubMed ID: 19754398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.